Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 6,278 shares at $56.48 ($355K) on 2021-05-25, disclosed to the SEC on 2021-05-27.
Seasonal sale ($355k) by Director — this insider has traded EBS in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.48 | 3,139 | $177K | 50.0% |
| 2 | $56.48 | 3,139 | $177K | 50.0% |
| Total | $56.48 avg | 6,278 | $355K | 100% |
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |